Impact of Male Human Papillomavirus (HPV) Vaccination on HPV Infection and HPV‐Related Diseases: A Systematic Review
Reviews in Medical Virology · 2026
DOI: 10.1002/rmv.70171 ↗At a glance
Systematische Übersicht in Reviews in Medical Virology, 2026. Written by Anna Beltrame and 5 co-authors. Institution: Center for Immunization and Infection Research in Cancer (CIIRC), H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Major MEDLINE topics: Papillomavirus Infections, Papillomavirus Vaccines, Human Papillomavirus Viruses, Vaccination. Cited 5 times so far (Crossref); 66 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: FURTHERMORE grants in publishing.
Abstract (original language)
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and is responsible for anogenital warts and several cancers. Although the effectiveness of female HPV vaccination has been well established since its introduction in 2006, no systematic review has specifically evaluated the impact of male vaccination programs introduced in 2011. We synthesised real‐world evidence on gender‐neutral vaccination (GNV), identifying 17 studies reporting rates of HPV infection, anogenital warts, and HPV‐related cancers during the pre‐ and post‐GNV periods among males in high‐income countries. Overall, we found limited but consistent evidence of benefit in males, although some of the observed reductions may also reflect herd immunity effects from earlier female‐only HPV vaccination programs. Only two studies evaluated temporal trends in HPV infection, both demonstrating reductions in vaccine‐targeted genotypes, although important methodological limitations restrict generalisability. Eight studies reported consistent declines in anogenital warts among adolescents and young adults, supporting a beneficial population‐level impact of GNV. Analyses of HPV‐related cancers showed an overall increasing incidence, likely reflecting long latency periods. However, some studies reported encouraging declines in cancer incidence among younger age groups. Oropharyngeal incidence decreased by 11%–19% among U.S. males aged 20–44 years, and penile cancer incidence decreased by 6%–38% among those aged 15–34 years. In Texas, penile and anal cancer incidence decreased by 35% and 16%, respectively, among males 20 years or older, while in Austria, anal cancer incidence decreased by 38% among men aged 30–39 years. Given the relatively recent introduction of male vaccination programs, longer follow‐up is required to fully assess their impact. Studies in low‐ and middle‐income countries are urgently needed.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Immunization and Infection Research in Cancer (CIIRC), H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
- Department of Laboratory Diagnostic & Investigative Sciences, University of Zimbabwe, Medical Microbiology Unit, Harare, Zimbabwe.
- Merck & Co., Inc., Rahway, New Jersey, USA.
- Biostatistics and Bioinformatics Shared Resource, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
- Biomedical Library, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Funding
- FURTHERMORE grants in publishing
Cite
APA
Beltrame, A., Dube Mandishora, R. S., Wang, W. V., Fan, W., Haver, M. K., & Giuliano, A. R. (2026). Impact of Male Human Papillomavirus (HPV) Vaccination on HPV Infection and HPV‐Related Diseases: A Systematic Review. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70171
Vancouver
Beltrame A, Dube Mandishora RS, Wang WV, Fan W, Haver MK, Giuliano AR. Impact of Male Human Papillomavirus (HPV) Vaccination on HPV Infection and HPV‐Related Diseases: A Systematic Review. Reviews in Medical Virology. 2026. doi:10.1002/rmv.70171
BibTeX
@article{Beltrame2026,
author = {Beltrame, Anna and Dube Mandishora, Racheal S and Wang, Wei Vivian and Fan, Wenyi and Haver, Mary Katherine and Giuliano, Anna R},
title = {Impact of Male Human Papillomavirus (HPV) Vaccination on HPV Infection and HPV‐Related Diseases: A Systematic Review},
journal = {Reviews in Medical Virology},
year = {2026},
doi = {10.1002/rmv.70171}
}
EUVIMED